FDA Inspection 1063802 — Servy Institute For Reproductive Endocrinology
The FDA completed an inspection of Servy Institute For Reproductive Endocrinology on Jul 17, 2018 in Augusta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 17, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Augusta, GA (United States)